Texas AG says Canadian Rx-buying is illegal
New legislation in the US state of Texas which seeks to allow state residents to purchase their prescription medicines from Canada is illegal, according to the state's Attorney General, Greg Abbott.
The state legislature approved the statute early in 2005 as part of wider legislation to re-create the Texas State Board of Pharmacy, but its enactment had been postponed following warnings from the Food and Drug Administration concerning its legality and a subsequent request from the pharmacy board that AG Abbott should issue an opinion.
He has now ruled that the statute is in violation of the federal Food, Drug & Cosmetic Act's provision which states that not only to import but also to "cause" the importation of prohibited medications is an offense.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze